Page last updated: 2024-08-17

quinoxalines and ly-2157299

quinoxalines has been researched along with ly-2157299 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cong, L; Xia, ZK; Yang, RY	1

Other Studies

1 other study(ies) available for quinoxalines and ly-2157299

Article	Year
Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy. Archiv der Pharmazie, 2014, Volume: 347, Issue:9 Topics: Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Molecular Targeted Therapy; Morpholines; Protein Binding; Protein Kinase Inhibitors; Pyrazoles; Quinolines; Quinoxalines; Receptors, Transforming Growth Factor beta; Scleroderma, Systemic	2014

Article

Year

Targeting the TGF-β receptor with kinase inhibitors for scleroderma therapy.

Archiv der Pharmazie, 2014, Volume: 347, Issue:9

Topics: Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Molecular Targeted Therapy; Morpholines; Protein Binding; Protein Kinase Inhibitors; Pyrazoles; Quinolines; Quinoxalines; Receptors, Transforming Growth Factor beta; Scleroderma, Systemic

2014